Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Chimeric Therapeutics Limited has announced an application for the quotation of new securities on the stock market, specifically 6,315,790 ordinary fully paid shares under the ASX code CHM, following a placement agreement made on June 23, 2023. This move, dated May 30, 2024, could signal a strategic expansion for investors to watch.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.
